z-logo
Premium
Reproducibility of peripheral arterial tonometry measurements in male cardiovascular patients
Author(s) -
Nil Markus,
Schäfer Daniela,
Radtke Thomas,
Saner Hugo,
Wilhelm Matthias,
Eser Prisca
Publication year - 2014
Publication title -
european journal of clinical investigation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.164
H-Index - 107
eISSN - 1365-2362
pISSN - 0014-2972
DOI - 10.1111/eci.12341
Subject(s) - reproducibility , intraclass correlation , medicine , cardiology , coefficient of variation , coronary artery disease , framingham heart study , peripheral , population , framingham risk score , mathematics , disease , statistics , environmental health
Background Assessment of endothelial function of the microvasculature by peripheral arterial tonometry (Endo PAT ® ) has gained increasing popularity in patients with cardiovascular risk factors. Only limited knowledge about its reproducibility in patients with coronary artery disease ( CAD ) is available. We therefore aimed to quantify reproducibility of Endo PAT ® parameters in patients with stable CAD . Design Endo PAT ® measurements were performed repeatedly in 78 male patients (age 66 ± 8 years) with CAD on stable medication. We calculated overall mean, standard deviation ( SD ), coefficient of variation ( CV ) and intraclass correlation coefficient ( ICC ) of the following parameters: reactive hyperemic index ( RHI ), PAT ratio of the postocclusion period 90–150 s as used for calculation of the RHI ( PAT ratio 90–150 s ) and 90–120 s ( PAT ratio 90–120 s ) as used for the often employed Framingham RHI (F‐ RHI ), as well as PAT ratio of the peak hyperemic response ( PAT ratio peak response ). Additionally, least significant changes ( LSC ) for individual subjects and minimum sample sizes for parallel and cross‐over design studies were calculated. Results Mean RHI was 1·84 ( SD 0·36). For RHI , PAT ratio 90–150 s , PAT ratio 90–120 s , and PAT ratio peak response the CV s were 17·0%, 25·4%, 26·1%, and 25·0%, respectively. The ICC s were 0·45, 0·49, 0·48 and 0·51, respectively, and LSC for RHI was 47·2%. Conclusions CV of RHI in our population was moderate; however, we consider this precision insufficient to monitor changes in individual patients, as they would need to exceed 47% to show a significant change. Further, the poor ICC s reflect the difficulty of detecting treatment effects in homogenous populations, such as patients with stable CAD .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom